Sarah Thacker, PhD is a former Principle Scientist in the cell biology R&D group, at Lonza’s Center for Cell Excellence in Durham, NC, USA. While at Lonza Sarah lead R&D project initiatives to enable new product development as well as improvement upon existing products in the cell biology portfolio. Prior to working at Lonza, Sarah was a Biology Lead at Vitrisa Therapeutics, which involved developing biochemical and cell-based assays to screen and advance lead compounds targeted to treat ocular indications. Sarah holds a Ph.D. in Pharmaceutical Sciences from the University of North Carolina at Chapel Hill, Eshelman School of Pharmacy, and a Bachelor of Science in Chemistry from Washington College.